跳至主要内容
临床试验/ITMCTR2100004263
ITMCTR2100004263招募中1 期

Observation on the curative effect of Qingdu powder applied by Yi medicine on dampness-heat obstruction syndrome of acute gouty arthritis

Yunnan Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • (1) Those who meet the diagnostic criteria of Western medicine for acute gouty arthritis and the syndrome differentiation criteria of traditional Chinese medicine for dampness-heat obstruction.
  • (2) The age range is from 18 to 70, and gender is not limited.
  • (3) The course of the attack is less than 5 days.
  • (4) No ulceration of the skin at the site of arthritis.
  • (5) The joint pain sites are knee joint, ankle joint or the first metatarsophalangeal joint.
  • (6) Patients are willing to be tested and give informed consent.

排除标准

  • (1) Secondary gout, joint lesions caused by diseases such as rheumatoid arthritis, silver-dural arthritis, pseudogout and lupus erythematosus. Chemotherapy, radiotherapy, acute obstructive nephropathy and other joint lesions;
  • (2) Patients with advanced deformity, disability, loss of labor force, and cardiovascular and cerebrovascular diseases induced by pain;
  • (3) Severe heart, brain, liver, kidney and other complications or other serious primary diseases, such as tumor or AIDS;
  • (4) Pregnant and lactating women;
  • (5) Unbearable severe joint pain (patient rating 10);
  • (6) People with mental or legal disabilities;
  • (7) People with allergic constitution (especially those who are allergic to plaster) and known to be allergic to the components of this medicine;
  • (8) According to the researcher's judgment, other lesions that reduce the possibility of enrolment or complicate enrolment, such as frequent changes in the work environment, may easily lead to loss of follow-up;
  • (9) Participating in other clinical trials.

研究者

相似试验